The shot, paired with Merck's Keytruda, cut the risk of melanoma recurrence in a trial of more than 1,100 patients.

Source: [Fortune](https://fortune.com/article/moderna-merck-mrna-vaccine-promise-deadly-skin-cancer-melanoma-stocks-08-19-2026/)

Sponsored